Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000201:enzymology*; D001923:Brain Chemistry; D002395:Catecholamines / Q000032:analysis; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D007520:Isocarboxazid / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008856:Microscopy, Fluorescence; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009526:Nialamide / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology*; D010624:Phenelzine / Q000494:pharmacology*; D012701:Serotonin / Q000032:analysis; D014191:Tranylcypromine / Q000494:pharmacology*
D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D007520:Isocarboxazid; D014191:Tranylcypromine; D004295:Dihydroxyphenylalanine; D010293:Pargyline; D006916:5-Hydroxytryptophan; D008995:Monoamine Oxidase; D010624:Phenelzine; D009526:Nialamide